Prothena Corp Public (PRTA) Net Cash Flow Growth (5y) (2017 - 2026)
Prothena Corp Public (PRTA) Net Cash Flow Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,184.45 Bn | 68,184.17 Bn | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 474.39 Bn | 469.59 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.21 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.43 Bn | 63.43 Bn | - |
| 8 | Argenx Se | 56.67 Bn | 51.49 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.08 Bn | 38.08 Bn | - |
| 10 | Prothena Corp Public | 483.38 Mn | 153.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.36% |
| Dec 31, 2025 | -4.02% |
| Sep 30, 2025 | -15.89% |
| Jun 30, 2025 | -19.93% |
| Mar 31, 2025 | -18.33% |
| Dec 31, 2024 | -26.84% |
| Sep 30, 2024 | -37.31% |
| Jun 30, 2024 | 27.42% |
| Mar 31, 2024 | -32.73% |
| Dec 31, 2023 | -16.90% |
| Sep 30, 2023 | 18.53% |
| Jun 30, 2023 | -19.86% |
| Mar 31, 2023 | -32.74% |
| Dec 31, 2022 | 50.06% |
| Sep 30, 2022 | 3.42% |
| Jun 30, 2022 | 0.36% |
| Mar 31, 2022 | -18.14% |
| Dec 31, 2021 | 0.60% |
| Sep 30, 2021 | 50.75% |
| Jun 30, 2021 | 32.51% |